Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 3.65 M3.12 M3.22 M7 M4.41 M 17.75 M Research & development 10.84 M-430 K5.01 M4.1 M7.58 M 16.26 M Operating income -14.49 M-2.69 M-8.23 M-11.1 M-11.99 M -34.01 M Non-Operating Income, Total ————-91 K — Interest expense, net of interest capitalized 36 K29 K19 K6 000674 K 728 K Non-Operating Income, excl. Interest Expenses ————-765 K — Unusual income/expense ————— — Pretax income -3.66 M-3.13 M-3.22 M-7 M-12.08 M -25.43 M Equity in earnings ————— — Taxes ———-33.14 M— — Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations -14.04 M-2.07 M-8.21 M-14.65 M-12.27 M -37.19 M Discontinued operations ————— — Net income -14.04 M-2.07 M-8.21 M-14.65 M-12.27 M -37.19 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders -14.04 M-2.07 M-8.21 M-14.65 M-12.27 M -37.19 M Basic earnings per share (Basic EPS) -24-3.5-14.58-8.8-8.94 -35.82 Diluted earnings per share (Diluted EPS) -24-3.5-14.58-8.8-8.94 -35.82 Average basic shares outstanding 585.93 K591.14 K563.07 K766.6 K1.37 M — Diluted shares outstanding 585.93 K591.14 K563.07 K766.6 K1.37 M — EBITDA ————— — EBIT -14.49 M-2.69 M-8.23 M-11.1 M-12.39 M -34.41 M Cost of revenue ————— — Other cost of goods sold ————— — Depreciation & amortization (cash flow) ————— —